Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06610110

Caffeine, CYPA12 and Resistance Exercise

Influence of CYP1A2 on the Acute Effect of Caffeine Intake on Resistance Exercise

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Alberto Pérez-López · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Introduction: Several studies have evaluated and confirmed the ergogenic effect of acute caffeine intake on sports performance, specifically on strength and power performance. However, it remains to be elucidated how CYP1A2 polymorphism influences the acute effects of caffeine on this type of exercise. Objectives: The present study aims to analyze the effects of acute caffeine intake on muscular strength, power, and endurance performance according to CYP1A2 polymorphism in men and women.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCaffeineAcute caffeine intake (3 mg/kg)
DIETARY_SUPPLEMENTPlaceboPlacebo (3 mg/kg maltodextrin)

Timeline

Start date
2024-04-01
Primary completion
2025-07-30
Completion
2025-07-30
First posted
2024-09-24
Last updated
2024-09-24

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT06610110. Inclusion in this directory is not an endorsement.

Caffeine, CYPA12 and Resistance Exercise (NCT06610110) · Clinical Trials Directory